A critical analysis of the 'amyloid cascade hypothesis'

Richard A. Armstrong

Research output: Contribution to journalArticle

Abstract

The 'amyloid cascade hypothesis' (ACH) is the most influential model of the pathogenesis of Alzheimer's disease (AD). The hypothesis proposes that the deposition of β-amyloid (Aβ) is the initial pathological event in AD, leading to the formation of extracellular senile plaques (SP), tau-immunoreactive neurofibrillary tangles (NFT), neuronal loss, and ultimately, clinical dementia. Ever since the formulation of the ACH, however, there have been questions regarding whether it completely describes AD pathogenesis. This review critically examines various aspects of the ACH including its origin and development, the role of amyloid precursor protein (APP), whether SP and NFT are related to the development of clinical dementia, whether Aβ and tau are 'reactive' proteins, and whether there is a pathogenic relationship between SP and NFT. The results of transgenic experiments and treatments for AD designed on the basis of the ACH are also reviewed. It was concluded: (1) Aβ and tau could be the products rather than the cause of neuro-degeneration in AD, (2) it is doubtful whether there is a direct causal link between Aβ and tau, and (3) SP and NFT may not be directly related to the development of dementia, (4) transgenic models involving APP alone do not completely replicate AD pathology, and (5) treatments based on the ACH have been unsuccessful. Hence, a modification of the ACH is proposed which may provide a more complete explanation of the pathogenesis of AD.

Original languageEnglish
Pages (from-to)211-225
Number of pages15
JournalFolia Neuropathologica
Volume52
Issue number3
DOIs
Publication statusPublished - 31 Mar 2014

Fingerprint

Amyloid
Neurofibrillary Tangles
Amyloid Plaques
Alzheimer Disease
Dementia
Amyloid beta-Protein Precursor
tau Proteins
Pathology

Bibliographical note

Creative Commons Attribution Non-Commercial Share Alike International 4.0

Keywords

  • Alzheimer's disease
  • amyloid cascade hypothesis
  • disease pathogenesis
  • neurofibrillary tangles
  • β-amyloid

Cite this

Armstrong, Richard A. / A critical analysis of the 'amyloid cascade hypothesis'. In: Folia Neuropathologica. 2014 ; Vol. 52, No. 3. pp. 211-225.
@article{449d856601894341a4f8f2dd893f97e4,
title = "A critical analysis of the 'amyloid cascade hypothesis'",
abstract = "The 'amyloid cascade hypothesis' (ACH) is the most influential model of the pathogenesis of Alzheimer's disease (AD). The hypothesis proposes that the deposition of β-amyloid (Aβ) is the initial pathological event in AD, leading to the formation of extracellular senile plaques (SP), tau-immunoreactive neurofibrillary tangles (NFT), neuronal loss, and ultimately, clinical dementia. Ever since the formulation of the ACH, however, there have been questions regarding whether it completely describes AD pathogenesis. This review critically examines various aspects of the ACH including its origin and development, the role of amyloid precursor protein (APP), whether SP and NFT are related to the development of clinical dementia, whether Aβ and tau are 'reactive' proteins, and whether there is a pathogenic relationship between SP and NFT. The results of transgenic experiments and treatments for AD designed on the basis of the ACH are also reviewed. It was concluded: (1) Aβ and tau could be the products rather than the cause of neuro-degeneration in AD, (2) it is doubtful whether there is a direct causal link between Aβ and tau, and (3) SP and NFT may not be directly related to the development of dementia, (4) transgenic models involving APP alone do not completely replicate AD pathology, and (5) treatments based on the ACH have been unsuccessful. Hence, a modification of the ACH is proposed which may provide a more complete explanation of the pathogenesis of AD.",
keywords = "Alzheimer's disease, amyloid cascade hypothesis, disease pathogenesis, neurofibrillary tangles, β-amyloid",
author = "Armstrong, {Richard A.}",
note = "Creative Commons Attribution Non-Commercial Share Alike International 4.0",
year = "2014",
month = "3",
day = "31",
doi = "10.5114/fn.2014.45562",
language = "English",
volume = "52",
pages = "211--225",
journal = "Folia Neuropathologica",
issn = "1641-4640",
publisher = "Polish Association of Neuropathologists",
number = "3",

}

A critical analysis of the 'amyloid cascade hypothesis'. / Armstrong, Richard A.

In: Folia Neuropathologica, Vol. 52, No. 3, 31.03.2014, p. 211-225.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A critical analysis of the 'amyloid cascade hypothesis'

AU - Armstrong, Richard A.

N1 - Creative Commons Attribution Non-Commercial Share Alike International 4.0

PY - 2014/3/31

Y1 - 2014/3/31

N2 - The 'amyloid cascade hypothesis' (ACH) is the most influential model of the pathogenesis of Alzheimer's disease (AD). The hypothesis proposes that the deposition of β-amyloid (Aβ) is the initial pathological event in AD, leading to the formation of extracellular senile plaques (SP), tau-immunoreactive neurofibrillary tangles (NFT), neuronal loss, and ultimately, clinical dementia. Ever since the formulation of the ACH, however, there have been questions regarding whether it completely describes AD pathogenesis. This review critically examines various aspects of the ACH including its origin and development, the role of amyloid precursor protein (APP), whether SP and NFT are related to the development of clinical dementia, whether Aβ and tau are 'reactive' proteins, and whether there is a pathogenic relationship between SP and NFT. The results of transgenic experiments and treatments for AD designed on the basis of the ACH are also reviewed. It was concluded: (1) Aβ and tau could be the products rather than the cause of neuro-degeneration in AD, (2) it is doubtful whether there is a direct causal link between Aβ and tau, and (3) SP and NFT may not be directly related to the development of dementia, (4) transgenic models involving APP alone do not completely replicate AD pathology, and (5) treatments based on the ACH have been unsuccessful. Hence, a modification of the ACH is proposed which may provide a more complete explanation of the pathogenesis of AD.

AB - The 'amyloid cascade hypothesis' (ACH) is the most influential model of the pathogenesis of Alzheimer's disease (AD). The hypothesis proposes that the deposition of β-amyloid (Aβ) is the initial pathological event in AD, leading to the formation of extracellular senile plaques (SP), tau-immunoreactive neurofibrillary tangles (NFT), neuronal loss, and ultimately, clinical dementia. Ever since the formulation of the ACH, however, there have been questions regarding whether it completely describes AD pathogenesis. This review critically examines various aspects of the ACH including its origin and development, the role of amyloid precursor protein (APP), whether SP and NFT are related to the development of clinical dementia, whether Aβ and tau are 'reactive' proteins, and whether there is a pathogenic relationship between SP and NFT. The results of transgenic experiments and treatments for AD designed on the basis of the ACH are also reviewed. It was concluded: (1) Aβ and tau could be the products rather than the cause of neuro-degeneration in AD, (2) it is doubtful whether there is a direct causal link between Aβ and tau, and (3) SP and NFT may not be directly related to the development of dementia, (4) transgenic models involving APP alone do not completely replicate AD pathology, and (5) treatments based on the ACH have been unsuccessful. Hence, a modification of the ACH is proposed which may provide a more complete explanation of the pathogenesis of AD.

KW - Alzheimer's disease

KW - amyloid cascade hypothesis

KW - disease pathogenesis

KW - neurofibrillary tangles

KW - β-amyloid

UR - http://www.scopus.com/inward/record.url?scp=84907512825&partnerID=8YFLogxK

UR - https://www.termedia.pl/Journal/-20/Streszczenie-23572

U2 - 10.5114/fn.2014.45562

DO - 10.5114/fn.2014.45562

M3 - Article

VL - 52

SP - 211

EP - 225

JO - Folia Neuropathologica

JF - Folia Neuropathologica

SN - 1641-4640

IS - 3

ER -